Key Details
Catalog |
MAS-0124-YJ18 |
Applications |
ELISA; Neut |
Host |
Mouse |
Reactivity |
B. anthracis |
Clonality |
Monoclonal |
Conjugations |
Conjugation could be customized |
Overview
Properties
Target
Related Products
Overview
Description
|
Clones 3A11, 4D12 and 1A13 are Mouse monoclonal IgGs recognize B. anthracis PA. All these three antibodies have neutralization activity. 3A11 binds to a epitope located in domain 4 (aa 596-735), while 4D12 and 1A13 bind to epitopes located in domain 2 (aa 250-488).
|
Reactivity
|
B. anthracis
|
Applications
|
ELISA; Neut
|
Host
|
Mouse
|
Immunogen
|
Recombinant anthrax protective antigen expressed in E. coli.
|
Isotype
|
3A11, 4D12: IgG1 1A13: IgG2a
|
Clonality
|
Monoclonal
|
Clone
|
3A11; 4D12; 1A13
|
Dilutions
|
ELISA: 0.1-1000 ng/mL
|
Properties
Expression Host
|
HEK293F/CHO
|
Conjugations
|
Conjugation could be customized
|
Purification
|
Protein A/G affinity purified is the regular method
|
Purity
|
SDS-PAGE> 95%
|
Endotoxin Level
|
Endotoxin level could be customized
|
Form
|
Liquid (frequently-used) or lyophilized
|
Concentration
|
About 1mg/ml. There are differences between batches. Special concentration could be customized.
|
Sterility
|
0.2 μM filtered
|
Buffer
|
See the Datasheet
|
Storage
|
See the Datasheet
|
Target
Target
|
B. anthracis PA
|
Alternative Names
|
PA; PA83; Pag; PagA; Protective antigen; Bacillus anthracis; B. anthracis; Bacillus anthracis
|
Introduction
|
Anthrax toxins are composed of three distinct proteins, a protective antigen (PA), a lethal factor (LF) and an edema factor (EF). None of these proteins are toxic by themselves and several studies indicate that the anthrax toxin has the familiar A-B enzymatic binding structure, with PA acting as the binding domain and EF and/or LF acting as the active fragments.
|
Organism
|
Bacteria
|
Related Disease
|
Anthrax
|
Infections Route
|
Cutaneous; Inhalation; Gastrointestinal; Injection
|